<code id='7FA6CB9D95'></code><style id='7FA6CB9D95'></style>
    • <acronym id='7FA6CB9D95'></acronym>
      <center id='7FA6CB9D95'><center id='7FA6CB9D95'><tfoot id='7FA6CB9D95'></tfoot></center><abbr id='7FA6CB9D95'><dir id='7FA6CB9D95'><tfoot id='7FA6CB9D95'></tfoot><noframes id='7FA6CB9D95'>

    • <optgroup id='7FA6CB9D95'><strike id='7FA6CB9D95'><sup id='7FA6CB9D95'></sup></strike><code id='7FA6CB9D95'></code></optgroup>
        1. <b id='7FA6CB9D95'><label id='7FA6CB9D95'><select id='7FA6CB9D95'><dt id='7FA6CB9D95'><span id='7FA6CB9D95'></span></dt></select></label></b><u id='7FA6CB9D95'></u>
          <i id='7FA6CB9D95'><strike id='7FA6CB9D95'><tt id='7FA6CB9D95'><pre id='7FA6CB9D95'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:1
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Medicare has a new plan to address drug shortages
          Medicare has a new plan to address drug shortages

          Medicarehasanewproposaltopayhospitalsmoretostockpileessentialdrugs,anefforttoavoidshortagesofchemoth

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          At Orexo, a ‘turning point’ for everything but digital health

          AdobeMosteverythingislookingupforOrexo,thecompanyreportedonitssecondquarterearningscallonTuesday.Tha